Neoplasms Malignant Completed Phase 1 Trials for Docetaxel (DB01248)

Also known as: Malignant Tumor / Neoplasm Malignant / Malignant Tumors / Malignant Neoplasm / Malignant Neoplasms / Neoplasm, Malignant / Neoplasms, Malignant / Disorder: Primary malignant neoplasm (disorder) / Malignant tumor (disorder) / Malignant neoplasms (& carcinoma) / Malignant neoplasm NOS (& sarcoma NOS) / Malignant neoplasm NOS / (Neoplasms) or (cancers) / Cancer NOS / Cancer / Malignant neoplasm of unspecified site NOS (disorder) / Ca - unspecified site NOS (disorder) / Ca - unspecified site NOS / (Ca unspecified site) or (secondary - unknown site) / Malignant tumour / [X]Malignant neoplasm without specification of site (disorder) / Malignant neoplasm of unspecified site (disorder) / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0047288 (Neoplasms Malignant)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01095302Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid TumorsTreatment
NCT01148615A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid TumorsTreatment